Exogenous lipoid pneumonia due to chronic inhalation of oily product used as a lubricant of tracheotomy cannula

Antonio Tancredi, Paolo Graziano, Roberto Scaramuzzi, Gerardo Scaramuzzi, Illuminato Carosi, Vito Attino, Antonello Cuttitta, Marco Taurchini

Research output: Contribution to journalArticle

Abstract

Exogenous lipoid pneumonia (ELP) is caused by the inhalation of vaporized oily products. Long-term exposure can result in chronic disease, whereas acute form usually results from massive aspiration of fatty substances. It has an incidence of 1.0%–2.5%. In case of symptomatic patients, the clinical presentation mainly includes acute or chronic respiratory symptoms such as dyspnea, fever, cough and less frequently chest pain, hemoptysis, or weight loss. Radiological findings are often aspecific or misinterpreted, and ELP is sometimes misdiagnosed as a malignancy of the lungs. Patient history and radiological findings can lead to a suspicion of ELP, but histological microscopic findings of intra-alveolar lipid and lipid-laden macrophages are required to confirm the diagnosis The mainstay of treatment consists of avoiding ongoing exposure and providing supportive care as repeated whole-lung lavage, corticosteroids, and/or immunoglobulins. Surgery is reserved for cases of high suspicion of cancer or serious clinical impact (as recurrent infections). Prognosis is benign, even if it has been reported cases of progression to severe respiratory failure, cor pul-monale, superinfection, and association with lung cancer. Here, we describe a case of ELP due to chronic inhalation of oily product (Vaseline) used as a lubricant of tracheotomy cannula.

Original languageEnglish
Pages (from-to)125-127
Number of pages3
JournalEurasian Journal of Medicine
Volume50
Issue number2
DOIs
Publication statusPublished - Jun 1 2018

Fingerprint

Lubricants
Tracheotomy
Inhalation
Pneumonia
Petrolatum
Lipids
Superinfection
Hemoptysis
Bronchoalveolar Lavage
Diagnostic Errors
Chest Pain
Cough
Respiratory Insufficiency
Dyspnea
Immunoglobulins
Weight Loss
Lung Neoplasms
Neoplasms
Adrenal Cortex Hormones
Chronic Disease

Keywords

  • Fatty lubricant
  • Lipoid pneumonia
  • Tracheotomy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Exogenous lipoid pneumonia due to chronic inhalation of oily product used as a lubricant of tracheotomy cannula. / Tancredi, Antonio; Graziano, Paolo; Scaramuzzi, Roberto; Scaramuzzi, Gerardo; Carosi, Illuminato; Attino, Vito; Cuttitta, Antonello; Taurchini, Marco.

In: Eurasian Journal of Medicine, Vol. 50, No. 2, 01.06.2018, p. 125-127.

Research output: Contribution to journalArticle

Tancredi, Antonio ; Graziano, Paolo ; Scaramuzzi, Roberto ; Scaramuzzi, Gerardo ; Carosi, Illuminato ; Attino, Vito ; Cuttitta, Antonello ; Taurchini, Marco. / Exogenous lipoid pneumonia due to chronic inhalation of oily product used as a lubricant of tracheotomy cannula. In: Eurasian Journal of Medicine. 2018 ; Vol. 50, No. 2. pp. 125-127.
@article{d6aafb751daa45c199606449ce1f72d5,
title = "Exogenous lipoid pneumonia due to chronic inhalation of oily product used as a lubricant of tracheotomy cannula",
abstract = "Exogenous lipoid pneumonia (ELP) is caused by the inhalation of vaporized oily products. Long-term exposure can result in chronic disease, whereas acute form usually results from massive aspiration of fatty substances. It has an incidence of 1.0{\%}–2.5{\%}. In case of symptomatic patients, the clinical presentation mainly includes acute or chronic respiratory symptoms such as dyspnea, fever, cough and less frequently chest pain, hemoptysis, or weight loss. Radiological findings are often aspecific or misinterpreted, and ELP is sometimes misdiagnosed as a malignancy of the lungs. Patient history and radiological findings can lead to a suspicion of ELP, but histological microscopic findings of intra-alveolar lipid and lipid-laden macrophages are required to confirm the diagnosis The mainstay of treatment consists of avoiding ongoing exposure and providing supportive care as repeated whole-lung lavage, corticosteroids, and/or immunoglobulins. Surgery is reserved for cases of high suspicion of cancer or serious clinical impact (as recurrent infections). Prognosis is benign, even if it has been reported cases of progression to severe respiratory failure, cor pul-monale, superinfection, and association with lung cancer. Here, we describe a case of ELP due to chronic inhalation of oily product (Vaseline) used as a lubricant of tracheotomy cannula.",
keywords = "Fatty lubricant, Lipoid pneumonia, Tracheotomy",
author = "Antonio Tancredi and Paolo Graziano and Roberto Scaramuzzi and Gerardo Scaramuzzi and Illuminato Carosi and Vito Attino and Antonello Cuttitta and Marco Taurchini",
year = "2018",
month = "6",
day = "1",
doi = "10.5152/eurasianjmed.2018.17325",
language = "English",
volume = "50",
pages = "125--127",
journal = "Eurasian Journal of Medicine",
issn = "1308-8734",
publisher = "Aves",
number = "2",

}

TY - JOUR

T1 - Exogenous lipoid pneumonia due to chronic inhalation of oily product used as a lubricant of tracheotomy cannula

AU - Tancredi, Antonio

AU - Graziano, Paolo

AU - Scaramuzzi, Roberto

AU - Scaramuzzi, Gerardo

AU - Carosi, Illuminato

AU - Attino, Vito

AU - Cuttitta, Antonello

AU - Taurchini, Marco

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Exogenous lipoid pneumonia (ELP) is caused by the inhalation of vaporized oily products. Long-term exposure can result in chronic disease, whereas acute form usually results from massive aspiration of fatty substances. It has an incidence of 1.0%–2.5%. In case of symptomatic patients, the clinical presentation mainly includes acute or chronic respiratory symptoms such as dyspnea, fever, cough and less frequently chest pain, hemoptysis, or weight loss. Radiological findings are often aspecific or misinterpreted, and ELP is sometimes misdiagnosed as a malignancy of the lungs. Patient history and radiological findings can lead to a suspicion of ELP, but histological microscopic findings of intra-alveolar lipid and lipid-laden macrophages are required to confirm the diagnosis The mainstay of treatment consists of avoiding ongoing exposure and providing supportive care as repeated whole-lung lavage, corticosteroids, and/or immunoglobulins. Surgery is reserved for cases of high suspicion of cancer or serious clinical impact (as recurrent infections). Prognosis is benign, even if it has been reported cases of progression to severe respiratory failure, cor pul-monale, superinfection, and association with lung cancer. Here, we describe a case of ELP due to chronic inhalation of oily product (Vaseline) used as a lubricant of tracheotomy cannula.

AB - Exogenous lipoid pneumonia (ELP) is caused by the inhalation of vaporized oily products. Long-term exposure can result in chronic disease, whereas acute form usually results from massive aspiration of fatty substances. It has an incidence of 1.0%–2.5%. In case of symptomatic patients, the clinical presentation mainly includes acute or chronic respiratory symptoms such as dyspnea, fever, cough and less frequently chest pain, hemoptysis, or weight loss. Radiological findings are often aspecific or misinterpreted, and ELP is sometimes misdiagnosed as a malignancy of the lungs. Patient history and radiological findings can lead to a suspicion of ELP, but histological microscopic findings of intra-alveolar lipid and lipid-laden macrophages are required to confirm the diagnosis The mainstay of treatment consists of avoiding ongoing exposure and providing supportive care as repeated whole-lung lavage, corticosteroids, and/or immunoglobulins. Surgery is reserved for cases of high suspicion of cancer or serious clinical impact (as recurrent infections). Prognosis is benign, even if it has been reported cases of progression to severe respiratory failure, cor pul-monale, superinfection, and association with lung cancer. Here, we describe a case of ELP due to chronic inhalation of oily product (Vaseline) used as a lubricant of tracheotomy cannula.

KW - Fatty lubricant

KW - Lipoid pneumonia

KW - Tracheotomy

UR - http://www.scopus.com/inward/record.url?scp=85049373714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049373714&partnerID=8YFLogxK

U2 - 10.5152/eurasianjmed.2018.17325

DO - 10.5152/eurasianjmed.2018.17325

M3 - Article

AN - SCOPUS:85049373714

VL - 50

SP - 125

EP - 127

JO - Eurasian Journal of Medicine

JF - Eurasian Journal of Medicine

SN - 1308-8734

IS - 2

ER -